Home/Filings/4/0001179110-18-007132
4//SEC Filing

BOLT WILLIAM J 4

Accession 0001179110-18-007132

CIK 0000815094other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 6:01 PM ET

Size

14.2 KB

Accession

0001179110-18-007132

Insider Transaction Report

Form 4
Period: 2018-05-16
BOLT WILLIAM J
SVP, QA and Regulatory Affairs
Transactions
  • Award

    Common Stock, $.01 par

    2018-05-16+1,40063,610 total
  • Award

    Stock Option (Right to Buy)

    2018-05-16+3,0003,000 total
    Exercise: $381.97From: 2019-05-16Exp: 2028-05-16Common Stock (3,000 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $66.25From: 2016-05-13Exp: 2025-05-13Common Stock (0 underlying)
    2,000
  • Stock Option (Right to Buy)

    Exercise: $134.51From: 2018-05-15Exp: 2027-05-15Common Stock (0 underlying)
    3,000
  • Stock Option (Right to Buy)

    Exercise: $99.62From: 2017-05-24Exp: 2026-05-24Common Stock (0 underlying)
    3,334
Footnotes (4)
  • [F1]Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
  • [F2]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
  • [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
  • [F4]Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 16, 2019, May 16, 2020 and May 16, 2021, so long as the reporting person continues to be employed by the issuer on the vesting dates.

Issuer

ABIOMED INC

CIK 0000815094

Entity typeother

Related Parties

1
  • filerCIK 0001199632

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 6:01 PM ET
Size
14.2 KB